APT Medical Inc. (SHA:688617)

APT Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,198	1,081	1,276	250.88	309.66	120.34
Trading Asset Securities	-	-	60	881.34	913.72	-
Cash & Short-Term Investments	1,198	1,081	1,336	1,132	1,223	120.34
Cash Growth	-2.62%	-19.10%	18.03%	-7.45%	916.56%	63.69%
Accounts Receivable	89.7	83.29	41.78	47.15	34.01	43.72
Other Receivables	7.22	6.51	8.76	14.14	13.45	5.97
Receivables	96.91	89.81	50.54	61.29	47.46	49.69
Inventory	419.38	399.32	327.95	337.94	263.25	145.27
Other Current Assets	36.87	46.48	41.18	26.01	19.15	34.96
Total Current Assets	1,751	1,617	1,756	1,557	1,553	350.26
Property, Plant & Equipment	696.1	671.58	464.46	319.93	258.73	155.11
Long-Term Investments	171.42	178.91	159.8	178.17	121.27	32.81
Goodwill	48.13	48.13	48.13	-	-	-
Other Intangible Assets	398.6	402	83	38.92	32.38	32.47
Long-Term Deferred Tax Assets	28.58	27.44	10.73	12.64	9.82	1.62
Long-Term Deferred Charges	3.01	3.4	5.95	5.09	7.41	1.62
Other Long-Term Assets	47.91	32.55	44.83	113.77	30.24	14.82
Total Assets	3,145	2,981	2,573	2,226	2,013	588.71
Accounts Payable	53.94	46.32	29.56	34.65	18	8.19
Accrued Expenses	73.84	142.58	161.28	119.18	94.68	62.14
Short-Term Debt	-	-	70	30	16	10.5
Current Portion of Long-Term Debt	7.12	6.42	1.18	7.27	6.09	5
Current Portion of Leases	-	-	10.1	6.26	7.46	-
Current Income Taxes Payable	54.29	35.4	19.86	13.3	9.35	3.38
Current Unearned Revenue	54.72	45.35	44.4	38.65	32.32	16.71
Other Current Liabilities	127.31	129.9	251.79	162.57	10.63	3.5
Total Current Liabilities	371.23	405.97	588.17	411.88	194.53	109.41
Long-Term Debt	-	-	0.59	1.77	10.23	23.59
Long-Term Leases	6.73	4.87	7.99	7.29	6.8	-
Long-Term Unearned Revenue	26.51	11.26	8.74	7.06	7.3	5.62
Long-Term Deferred Tax Liabilities	2.64	2.74	5.49	6.92	3.16	-
Other Long-Term Liabilities	1.02	1.02	-	-	-	-
Total Liabilities	408.14	425.85	610.98	434.91	222.02	138.62
Common Stock	97.08	97.39	66.86	66.67	66.67	50
Additional Paid-In Capital	726.49	784.5	724.04	1,013	1,268	159.47
Retained Earnings	1,870	1,685	1,141	716.83	425.49	250.9
Treasury Stock	-	-59.99	-59.99	-59.99	-	-
Comprehensive Income & Other	7.11	9.6	34.96	27.22	17.89	-0.01
Total Common Equity	2,701	2,516	1,907	1,763	1,778	460.36
Minority Interest	35.5	38.5	54.86	27.75	12.95	-10.27
Shareholders' Equity	2,736	2,555	1,962	1,791	1,791	450.09
Total Liabilities & Equity	3,145	2,981	2,573	2,226	2,013	588.71
Total Debt	13.86	11.29	89.86	52.59	46.58	39.09
Net Cash (Debt)	1,184	1,070	1,247	1,080	1,177	81.25
Net Cash Growth	-2.39%	-14.18%	15.46%	-8.26%	1348.33%	-
Net Cash Per Share	12.17	11.00	12.75	11.02	12.37	1.12
Filing Date Shares Outstanding	96.91	95.61	96.5	96.22	96.67	72.5
Total Common Shares Outstanding	96.91	95.61	96.5	96.67	96.67	72.5
Working Capital	1,380	1,211	1,168	1,146	1,359	240.85
Book Value Per Share	27.87	26.32	19.76	18.24	18.39	6.35
Tangible Book Value	2,254	2,066	1,776	1,724	1,746	427.89
Tangible Book Value Per Share	23.26	21.61	18.40	17.84	18.06	5.90
Buildings	-	-	173.2	150.44	81.94	69.27
Machinery	-	-	402.93	277.15	223.7	141.71
Construction In Progress	-	-	47.84	14.99	37.31	17.64

Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.